Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Myopia Control Spectacle Lens Cessation Study

NCT: NCT05893979 · ACTIVE_NOT_RECRUITING

NCT IDNCT05893979
StatusACTIVE_NOT_RECRUITING
Start Date2023-06-23
Completion2027-07-31

Brief Summary

To quantify myopic progression (cycloplegic spherical equivalent refraction - cSER) following the cessation of use of specific spectacle lenses. To quantify axial length progression following cessation of use of specific spectacle lenses.

Frequently Asked Questions

What is Myopia Control Spectacle Lens Cessation Study?

Myopia Control Spectacle Lens Cessation Study is a clinical trial registered under NCT05893979. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05893979?

The current status of NCT05893979 (Myopia Control Spectacle Lens Cessation Study) is: ACTIVE_NOT_RECRUITING.

When did Myopia Control Spectacle Lens Cessation Study start?

Myopia Control Spectacle Lens Cessation Study started on 2023-06-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑